BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6966324)

  • 1. Cerebrospinal fluid complement proteins in neurological disease.
    Price P; Cuzner ML
    J Neurol Sci; 1980 Apr; 46(1):49-54. PubMed ID: 6966324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinase inhibitors in cerebrospinal fluid in multiple sclerosis.
    Price P; Cuzner ML
    J Neurol Sci; 1979 Jul; 42(2):251-9. PubMed ID: 90128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid.
    Stendahl-Brodin L; Link H
    J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):102-5. PubMed ID: 7359146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
    Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
    Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients.
    Annunziata P; Volpi N
    Acta Neurol Scand; 1985 Jul; 72(1):61-4. PubMed ID: 4050318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system.
    Jongen PJ; Doesburg WH; Ibrahim-Stappers JL; Lemmens WA; Hommes OR; Lamers KJ
    Acta Neurol Scand; 2000 Feb; 101(2):116-21. PubMed ID: 10685859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complement 3 level in the cerebrospinal fluid in multiple sclerosis].
    Wajgt A
    Neurol Neurochir Pol; 1980; 14(3):275-82. PubMed ID: 7412984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1-antitrypsin in cerebrospinal fluid of patients with neurologic diseases.
    Pearl GS; Mullins RE
    Arch Neurol; 1985 Aug; 42(8):775-7. PubMed ID: 3875332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis.
    Yam P; Petz LD; Tourtellotte WW; Ma BI
    Clin Immunol Immunopathol; 1980 Dec; 17(4):492-505. PubMed ID: 7438567
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoglobulin levels in the cerebrospinal fluid.
    Riddoch D; Thompson RA
    Br Med J; 1970 Feb; 1(5693):396-9. PubMed ID: 4190842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The determination of the complement components C1q, C4 and C3 in serum and cerebrospinal fluid by radioimmunoassay.
    Dujardin BC; Driedijk PC; Roijers AF; Out TA
    J Immunol Methods; 1985 Jun; 80(2):227-37. PubMed ID: 3925023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF immunoglobulins in multiple sclerosis and other neurologic diseases. Measurement by electroimmunodiffusion.
    Schneck SA; Claman HN
    Arch Neurol; 1969 Feb; 20(2):132-9. PubMed ID: 4975014
    [No Abstract]   [Full Text] [Related]  

  • 13. T-lymphocyte subpopulation levels and immunoglobulin changes in the cerebrospinal fluid of patients with neurologic disorders.
    Pirttilä T; Antonen J; Syrjälä P; Frey H
    Ann N Y Acad Sci; 1987; 496():691-6. PubMed ID: 3496834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunonephelometric determination of proteins in cerebrospinal fluid in various neurological disorders.
    Baark JP; Berg O; Hemmingsen L
    Clin Chim Acta; 1983 Jan; 127(2):271-7. PubMed ID: 6337755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid proteins and serum immunoglobulins. Occurrence in multiple sclerosis and other neurological diseases: comparative measurement of gamma-globulin and the IgG class.
    Fischer-Williams M; Roberts RC
    Arch Neurol; 1971 Dec; 25(6):526-34. PubMed ID: 4107216
    [No Abstract]   [Full Text] [Related]  

  • 16. High resolution two-dimensional polyacrylamide gel electrophoresis of cerebrospinal fluid in patients with neurological diseases.
    Endler AT; Young DS; Yanagihara T; Currie RM; Reid J
    J Clin Chem Clin Biochem; 1987 Feb; 25(2):61-70. PubMed ID: 3553415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG ratios and oligoclonal IgG in multiple sclerosis and other neurological disorders.
    Perkin GD; Sethi K; Muller BR
    J Neurol Sci; 1983; 60(3):325-36. PubMed ID: 6631440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-resolved immunofluorometric assay of complement C3: application to cerebrospinal fluid.
    Gaillard O; Meillet D; Diemert MC; Musset L; Delattre J; Schuller E; Galli J
    Clin Chem; 1993 Feb; 39(2):309-12. PubMed ID: 8432021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agarose electrophoresis and immunonephelometric quantitation of cerebrospinal fluid immunoglobulins: criteria for application in the diagnosis of neurologic disease.
    Pearl GS; Check IJ; Hunter RL
    Am J Clin Pathol; 1984 May; 81(5):575-80. PubMed ID: 6720628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of the complement factors C3 and C4 within the central nervous system over the course of aseptic meningitis.
    Frydén A; Forsberg P; Link H
    Acta Neurol Scand; 1983 Sep; 68(3):157-63. PubMed ID: 6650127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.